CDMO Pharma Manufacturer (WHO-GMP) with Top Clientele & LVP Expansion Opportunity is up for Sale.

It is a well-established pharmaceutical manufacturing company engaged in the production of Dry Powder Injection, Dry Syrup, and Sterile Water for Injection. The company is currently undergoing upgradation to begin manufacturing Large Volume Parenterals (LVPs).

Business Model:

• Operates under a CDMO (Contract Development & Manufacturing Organization) model for Dry Powder Injection and Syrup.
• Long-standing relationships with top pharma players like Aristo, Akums, Glenmark, and Mankind.
• Works on a cost-plus model ensuring stable margins with low exposure to API price volatility.
• Sterile Water for Injection is sold under P2P (Product to Product) arrangements.

Manufacturing Facility:

• Two dedicated units:

  • One for Beta Lactam (Dry Injection & Syrup). Installed capacity is 1,20,000 units per day for dry powder injection and 80 thousand units per day of dry powder syrup

  • One for Sterile Water & LVPs (upgradation in progress)

• WHO-GMP certified and Schedule M compliant

• Undergoing regulatory audits for entry into multiple African countries

Products & Services

Existing Products:

1. Dry Powder Injections

2. Dry Powder Syrups

3. Sterile Water for Injection

Upcoming (Under Upgradation):

4. Large Volume Parenterals (LVPs) – e.g., IV fluids, saline, dextrose, etc.